141 related articles for article (PubMed ID: 8836914)
1. Treatment strategies for early-stage chronic lymphocytic leukemia: can interferon-inducible MxA protein and tumor necrosis factor play a role as predictive markers for response to interferon therapy?
Bezares F; Kohan S; Sacerdote de Lustig E; Farías E; Murro H; Horisberger MA
J Interferon Cytokine Res; 1996 Jul; 16(7):501-5. PubMed ID: 8836914
[TBL] [Abstract][Full Text] [Related]
2. Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy.
Antonelli G; Simeoni E; Turriziani O; Tesoro R; Redaelli A; Roffi L; Antonelli L; Pistello M; Dianzani F
J Interferon Cytokine Res; 1999 Mar; 19(3):243-51. PubMed ID: 10213463
[TBL] [Abstract][Full Text] [Related]
3. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus.
Fernández M; Quiroga JA; Martín J; Herrero M; Pardo M; Horisberger MA; Carreño V
J Infect Dis; 1999 Aug; 180(2):262-7. PubMed ID: 10395838
[TBL] [Abstract][Full Text] [Related]
5. MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment.
Kong XF; Zhang XX; Gong QM; Gao J; Zhang SY; Wang L; Xu J; Han Y; Jin GD; Jiang JH; Zhang DH; Lu ZM
J Interferon Cytokine Res; 2007 Sep; 27(9):809-18. PubMed ID: 17892402
[TBL] [Abstract][Full Text] [Related]
6. Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C.
Jakschies D; Zachoval R; Müller R; Manns M; Nolte KU; Hochkeppel HK; Horisberger MA; Deicher H; Von Wussow P
Hepatology; 1994 Apr; 19(4):857-65. PubMed ID: 8138257
[TBL] [Abstract][Full Text] [Related]
7. Alpha 2-interferon in B-cell chronic lymphocytic leukemia: clinical response, serum cytokine levels, and immunophenotype modulation.
Morabito F; Callea V; Oliva B; Stelitano C; Vincelli I; Molica S; Alberti A; Brugiatelli M; Nobile F
Leukemia; 1993 Mar; 7(3):366-71. PubMed ID: 7680399
[TBL] [Abstract][Full Text] [Related]
8. Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1.
Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Capobianco M; Bertolotto A
Mult Scler; 2006 Feb; 12(1):47-57. PubMed ID: 16459719
[TBL] [Abstract][Full Text] [Related]
9. Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.
Gallego A; Vargas JA; Castejón R; Citores MJ; Romero Y; Millán I; Durántez A
Cytometry B Clin Cytom; 2003 Nov; 56(1):23-9. PubMed ID: 14582134
[TBL] [Abstract][Full Text] [Related]
10. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy.
Jewell AP; Worman CP; Giles FJ; Goldstone AH
Leuk Lymphoma; 1997 Jan; 24(3-4):327-33. PubMed ID: 9156662
[TBL] [Abstract][Full Text] [Related]
12. MxA gene expression in peripheral blood mononuclear cells from patients infected chronically with hepatitis C virus treated with interferon-alpha.
Meier V; Mihm S; Ramadori G
J Med Virol; 2000 Nov; 62(3):318-26. PubMed ID: 11055241
[TBL] [Abstract][Full Text] [Related]
13. The proximal interferon-stimulated response elements are essential for interferon responsiveness: a promoter analysis of the antiviral MxA gene.
Ronni T; Matikainen S; Lehtonen A; Palvimo J; Dellis J; Van Eylen F; Goetschy JF; Horisberger M; Content J; Julkunen I
J Interferon Cytokine Res; 1998 Sep; 18(9):773-81. PubMed ID: 9781817
[TBL] [Abstract][Full Text] [Related]
14. [Genetic polymorphisms of MxA protein and eIF-2a-reg2 and their responses to interferon treatment in patients with chronic hepatitis B].
Huang YX; Ma LN; Chen XY; Li Z; Huang YL; Shen CL; Ma B
Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):187-91. PubMed ID: 17407708
[TBL] [Abstract][Full Text] [Related]
15. Interferon alfa-2b therapy in untreated early stage, B-chronic lymphocytic leukaemia patients: one-year follow-up.
Boussiotis VA; Pangalis GA
Br J Haematol; 1991 Oct; 79 Suppl 1():30-3. PubMed ID: 1931705
[TBL] [Abstract][Full Text] [Related]
16. Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-alpha-2a treatment.
Beksaç M; Arat M; Akan H; Koç H; Ilhan O; Ozcan M
Cancer; 2000 Oct; 89(7):1474-81. PubMed ID: 11013360
[TBL] [Abstract][Full Text] [Related]
17. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
18. Role of TNF-alpha as a survival prognostic marker in chronic lymphocytic leukemia patients.
Singer MK; Assem M; Abdel Ghaffar AB; Morcos NY
Egypt J Immunol; 2011; 18(1):51-60. PubMed ID: 23082480
[TBL] [Abstract][Full Text] [Related]
19. Induction of MxA mRNA in patients with neuroendocrine tumors after interferon treatment. Lack of correlation with antitumor response.
Imam H; Janson ET; Gobl A; Alm G; Oberg K
Anticancer Res; 1995; 15(5B):2191-5. PubMed ID: 8572623
[TBL] [Abstract][Full Text] [Related]
20. Low-dose "natural" alpha-interferon in B-cell derived chronic lymphocytic leukemia.
Pozzato G; Franzin F; Moretti M; Tulissi P; Pecorari P; Melato M; Zacchi T; Evangelisti P; Campanacci L
Haematologica; 1992; 77(5):413-7. PubMed ID: 1483591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]